Attached files

file filename
EX-32.1 - EXHIBIT 32.1 - ACELRX PHARMACEUTICALS INCex_232198.htm
EX-31.2 - EXHIBIT 31.2 - ACELRX PHARMACEUTICALS INCex_232197.htm
EX-31.1 - EXHIBIT 31.1 - ACELRX PHARMACEUTICALS INCex_232196.htm
EX-21.1 - EXHIBIT 21.1 - ACELRX PHARMACEUTICALS INCex_232194.htm
EX-10.18 - EXHIBIT 10.18 - ACELRX PHARMACEUTICALS INCex_232264.htm
EX-10.17 - EXHIBIT 10.17 - ACELRX PHARMACEUTICALS INCex_232262.htm
EX-4.1 - EXHIBIT 4.1 - ACELRX PHARMACEUTICALS INCex_232263.htm
10-K - FORM 10-K - ACELRX PHARMACEUTICALS INCacrx20201231_10k.htm

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in the following Registration Statements:

 

 

(i)

Registration Statement on Form S-8 (No. 333-239213) pertaining to the 2020 Equity Incentive Plan and Amended and Restated 2011 Employee Stock Purchase Plan,

 

 

(ii)

Registration Statements on Form S-8 (Nos. 333-230139, 333-223535, 333-216492, 333-202709, 333-194634 and 333-187206) pertaining to the 2011 Equity Incentive Plan,

     
  (iii) Registration Statements on Form S-8 (Nos. 333-237195, 333-209998 and 333-180334) pertaining to the 2011 Equity Incentive Plan and 2011 Employee Stock Purchase Plan,
     
  (iv) Registration Statement on Form S-8 (No. 333-172409) pertaining to the 2006 Stock Plan, 2011 Equity Incentive Plan and 2011 Employee Stock Purchase Plan, and
     
  (v) Registration Statement on Form S-3 (No. 333-239156)

 

of our report dated March 15, 2021 with respect to the consolidated financial statements and schedule of AcelRx Pharmaceuticals, Inc., which appears in this Annual Report on Form 10-K.

 

/s/ OUM & CO. LLP

 

San Francisco, California

March 15, 2021